Study sheds light on cancer burden in Australia
December 8, 2011 in CancerOver the past quarter century in Australia, cancer incidence rates have increased while deaths from cancer have steadily decreased. Those are some of the findings of a recent study published early online in the Asia-Pacific Journal of Clinical Oncology.
Compared with any other disease group, cancer has the greatest overall impact on Australians' health, with one in two Australians developing cancer and one in five dying from it before the age of 85. The Australian Institute of Health and Welfare has produced an up-to-date snapshot of cancer in the country based on its cancer data holdings and regular reports, including statistics on incidence, mortality, survival, and participation in national cancer screening programs.
The study provides information from 2007, trends from 1982 to 2007, and estimations for 2010. In 2007, a total of 108,368 new cases of cancer (excluding basal and squamous cell carcinoma of the skin) and 39,884 deaths from cancer occurred in Australia. Men were most often diagnosed with prostate cancer, while women were most often diagnosed with breast cancer. Lung cancer was by far the most common cause of cancer death in both males and females.
When looking at trends, the investigators found that the number of new cancer cases diagnosed each year increased from 1982 to 2007 for both males and females, which can be explained by the aging and increasing size of the population. In females, the overall cancer incidence rate rose from 1982 through the early 1990s, after which the rate remained relatively stable. In males, the overall cancer incidence rate rose from 1982 to 1994, followed by a decline in rates until the late 1990s, when rates began to rise again. From 1982 to 2007, cancer death rates have decreased steadily for both sexes, so that the five-year survival rates for many cancers have improved markedly since the 1980s.
The report uncovered certain disparities in cancer incidence and death rates in recent years. Most notably, the overall incidence rate of cancer for Indigenous Australians was lower than that for non-indigenous Australians, while the overall death rate from cancer was higher. More diagnoses at advanced stages, less uptake of cancer treatments, and a greater number of other illnesses may contribute to the higher death rates in Indigenous Australians.
To provide a more current picture of the cancer burden in Australia, the authors extrapolated their findings to 2010, noting that about 113,700 new cases of cancer (excluding basal and squamous cell carcinoma of the skin) were expected to be diagnosed last year. Of these, 63,200 were expected to be in males and 50,500 in females. Compared with the numbers of new cancer cases diagnosed in 2007, this equates to a 2 percent increase in males and a 9 percent increase in females, mainly due to aging and growth of the population. Prostate cancer, bowel cancer, and melanoma of the skin in males, and breast cancer, bowel cancer, and melanoma of the skin in females were expected to continue to be the most commonly diagnosed cancers in 2010.
The researchers also looked at rates of participation in Australia's national screening programs for breast, cervical, and bowel cancers. From 2007 to 2008, over 1.6 million women had a screening mammogram through BreastScreen Australia, which translates to a participation rate of 55 percent for women in the target age group of 50 to 69 years. During that same time, over 3.6 million women participated in the National Cervical Screening Program, a participation rate of 61 percent for women in the target age group of 20 to 69 years. Also, almost 280,000 people (40 percent of those invited) participated in the National Bowel Cancer Screening Program in 2008. More information about these programs can be found at http://www.cancerscreening.gov.au.
More information: Harding et al. Cancer in Australia: Actual Incidence and Mortality Data From 1982 to 2007 and Projections to 2010. Asia-Pacific Journal of Clinical Oncology 2011; DOI:10.1111/j.1743-7563.2011.01502.x
Journal reference:
Journal of Clinical Oncology
Provided by
Wiley
-
Australians have world's highest rate of skin cancer: study
Dec 16, 2010 |
not rated yet |
0
-
Certain types of cancer becoming more common, while rates of others decreasing
Dec 16, 2006 |
not rated yet |
0
-
Annual report to the nation focuses on brain tumors
Mar 31, 2011 |
not rated yet |
0
-
Higher incidence of secondary breast cancer seen among black women regardless of age
Sep 19, 2011 |
not rated yet |
0
-
Cancer deaths continue to drop
Jul 07, 2010 |
not rated yet |
0
-
Of mice and mental models: Neuroscientific implications of risk-optimized behavior in the mouse
May 25, 2012 |
not rated yet |
0
-
Limits to growth: Scientists identify key metastasis-enabling enzyme
May 22, 2012 |
5 / 5 (4) |
0
-
Seeing is as seeing does: Spatially-structured retinal input in early development of cortical maps
Apr 26, 2012 |
5 / 5 (4) |
1
-
Dreamless nights: Brain activity during nonrapid eye movement sleep
Apr 09, 2012 |
4.4 / 5 (12) |
0
-
Take your time: Neurobiology sheds light on the superiority of spaced vs. massed learning
Mar 28, 2012 |
4.5 / 5 (21) |
3
-
Potential Breakthrough in Seizure Control
14 hours ago
-
Popping/Cracked sternum.
19 hours ago
-
Which Mental Illness Encompasses This Problem?
19 hours ago
-
A question about drug tolerance
May 23, 2012
-
Poor nutrition leading to overeating?
May 23, 2012
-
Math and dyslexia?
May 21, 2012
- More from Physics Forums - Medical Sciences
More news stories
Skp2 activates cancer-promoting, glucose-processing Akt
HER2 and its epidermal growth factor receptor cousins mobilize a specialized protein to activate a major player in cancer development and sugar metabolism, scientists report in the May 25 issue of Cell.
Cancer
May 25, 2012 |
not rated yet |
0
|
Pancreatectomy OK without downstaging from therapy
(HealthDay) -- Pancreatectomy improves median survival in pancreatic cancer patients even when presurgical neoadjuvant therapy does not lead to radiographic downstaging of tumors, according to a study published ...
Cancer
May 25, 2012 |
not rated yet |
0
Common therapies for basal cell carcinoma offer similar survival
(HealthDay) -- For patients with superficial basal cell carcinoma (sBCC), treatment with imiquimod or photodynamic therapy (PDT) results in similar long-term tumor-free survival, according to a review published ...
Cancer
May 25, 2012 |
not rated yet |
0
Cancer may require simpler genetic mutations than previously thought
Chromosomal deletions in DNA often involve just one of two gene copies inherited from either parent. But scientists haven't known how a deletion in one gene from one parent, called a "hemizygous" deletion, can contribute ...
Cancer
May 25, 2012 |
not rated yet |
0
|
New prostate cancer screening guidelines face a tough sell, study suggests
(Medical Xpress) -- Recent recommendations from the U.S. Preventive Services Task Force (USPSTF) advising elimination of routine prostate-specific antigen (PSA) screening for prostate cancer in healthy men are likely to encounter ...
Cancer
May 25, 2012 |
not rated yet |
1
Travel to high altitudes tied to Crohn's, colitis flare-ups
(HealthDay) -- People with inflammatory bowel disease, which includes Crohn's disease and colitis, may be at increased risk for flare-ups when they fly or travel to high altitudes for skiing or mountain climbing, ...
Family history of Alzheimer's affects functional connectivity
(HealthDay) -- Cognitively normal individuals with a family history of late-onset Alzheimer's disease (AD) may display lower resting state functional connectivity in the default mode network (DMN) of the brain, ...
Transvaginal mesh op restores pelvic organ prolapse at price
(HealthDay) -- Transvaginal mesh (TVM) procedures are effective for anatomical restoration of pelvic organ prolapse (POP), but patients report a worsening of sexual function following surgery, according to ...
Of mice and mental models: Neuroscientific implications of risk-optimized behavior in the mouse
(Medical Xpress) -- Regardless of an organism’s biological complexity, every encephalized animal continuously makes under-informed behavioral choices that can have serious consequences. Despite its ubiquity, ...
Weight struggles? Blame new neurons in your hypothalamus
New nerve cells formed in a select part of the brain could hold considerable sway over how much you eat and consequently weigh, new animal research by Johns Hopkins scientists suggests in a study published in the May issue ...
Thioridazine kills cancer stem cells in human while avoiding toxic side-effects of conventional cancer treatments
A team of scientists at McMaster University has discovered a drug, thioridazine, successfully kills cancer stem cells in the human while avoiding the toxic side-effects of conventional cancer treatments.